Danone has expanded the line of products it sells in China for adults with special medical needs.

The French group already supplies its Nutrison and Peptisorb tube-feeding products in China for patients who cannot eat or swallow normally.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Danone has decided to add its Fortimel brand to its local portfolio. The company is selling Fortimel Balanced beverages made at its facility in Wuxi in eastern China.

The group pointed to the country’s ageing population and the rising “incidence of chronic disease”, as well as demand for “adequate nutritional care upon discharge” from hospital.

The drinks are “designed to meet the nutritional needs of patients recovering after surgery or non-communicable diseases like cancer and stroke”, Danone explained.

Bruno Chevot, the president of Danone’s business in China, north Asia and Oceania added: “It marks a solid step into the AFSMP [Adult Foods for Special Medical Purposes] market in China and helps Danone to further grow its portfolio covering the full life spectrum.”

Danone’s medical nutrition business is part of its wider “specialised nutrition” division, which also includes products for infants like baby food and formula. The company says medical nutrition products account for approximately 40% of the division’s sales.

Overall, the business unit accounts for 30% of Danone’s total revenues. It grew its revenues by 10% on a like-for-like basis in 2022.

Last month, Danone said it had invested €15m ($16m) to expand a factory in Turkey for medical nutrition products.